Masimo‘s (NSDQ:MASI) 1st quarter earnings, issued yesterday, missed the mark by just a hair as the company’s increased sales couldn’t outpace lost royalty revenues.
MassDevice Earnings Roundup
Kensey Nash agrees to $360M buyout by Royal DSM
Kensey Nash (NSDQ:KNSY) agreed to a $38.50-per-share cash buyout offer from Royal DSM worth about $360 million, a 33% premium over KNSY’s $29.01 closing price yesterday.
KNSY shares soared 32.2% in pre-market trading on the news, reaching $38.35 – 25.7% above its 52-week high of $30.50 per share, even as the company revealed a 3rd-quarter swing from red ink to black.
Thoratec kills it in Q1, Wall Street shrugs | Earnings Roundup
Thoratec (NSDQ:THOR) started today up 7.2% as investors reacted to its stellar 1st-quarter numbers, but by the time the market closed THOR shares had fallen back to Earth to close at $34.46, down 0.1%.
The heart pump maker posted profits of $25.5 million, or 43¢ per diluted share, on sales of $126.8 million for the 3 months ended March 31.
Thoratec kills it in Q1, Wall Street shrugs
Thoratec (NSDQ:THOR) started today up 7.2% as investors reacted to its stellar 1st-quarter numbers, but by the time the market closed THOR shares had fallen back to Earth to close at $34.46, down 0.1%.
The heart pump maker posted profits of $25.5 million, or 43¢ per diluted share, on sales of $126.8 million for the 3 months ended March 31.
Wright Medical doubles Wall Street’s forecast for Q1, shares soar
Wall Street showed some love for Wright Medical Group (NSDQ:WMGI) following the company’s Q1 report, in which adjusted earnings doubled analysts’ expectations.
NuVasive delights Wall Street with Q1 numbers
NuVasive Inc. (NSDQ:NUVA) CEO Alex Lukianov is aiming to take the #3 spot in the spinal implant market and has set his sights on the $1 billion sales mark, after NuVasive’s 1st-quarter results showed it taking market share from its larger rivals.
That seems to be music to Wall Street’s ears, as investors bid shares up more than 23% yesterday and analysts issued a slew of upgrades for the San Diego-based company.
MassDevice.com +3 | The top 3 med-tech stories for May 1, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
BD dips on Q2 results
Becton Dickinson & Co. (NYSE:BDX) shares lost about 1% today after the medical products maker reported lackluster 2nd-quarter results, despite beating Wall Street’s earnings expectations by a penny.
Teleflex gains on acquisitions, Q1 numbers | Wall Street Beat
Shares of Teleflex (NYSE:TFX) are up today after the medical device maker revealed a pair of acquisitions and earnings well above Wall Street’s expectations.
Limerick, Pa.-based Teleflex said it inked deals to buy the EZ-Blocker pulmonary catheter technology and Axiom Technology Partners, which makes the EFx line of laparoscopic fascial closure devices.